Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report.
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
Piglets inoculated by different routes are not susceptible to SARS-CoV-2, but those inoculated parenterally were immunized against the virus.
Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.